For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
Enovis Corp (NYSE: ENOV) closed the day trading at $29.5 down -1.67% from the previous closing price of $30.0. In other words, the price has decreased by -$1.67 from its previous closing price. On the day, 0.79 million shares were traded. ENOV stock price reached its highest trading level at $30.05 during the session, while it also had its lowest trading level at $29.365.
Ratios:
For a better understanding of ENOV, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.15 and its Current Ratio is at 2.25. In the meantime, Its Debt-to-Equity ratio is 0.57 whereas as Long-Term Debt/Eq ratio is at 0.55.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on October 03, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $62.
On June 13, 2024, JP Morgan started tracking the stock assigning a Neutral rating and target price of $53.
On February 13, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $72.Stephens initiated its Overweight rating on February 13, 2024, with a $72 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 20 ’25 when BERRY PHILLIP BENJAMIN (BEN) bought 2,500 shares for $29.71 per share. The transaction valued at 74,275 led to the insider holds 116,729 shares of the business.
PRYOR DANIEL A bought 10,000 shares of ENOV for $289,000 on Aug 13 ’25. The EVP, Strategy & Business Dev. now owns 161,115 shares after completing the transaction at $28.90 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ENOV now has a Market Capitalization of 1686214144 and an Enterprise Value of 3109685248. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.77 while its Price-to-Book (P/B) ratio in mrq is 0.65. Its current Enterprise Value per Revenue stands at 1.42 whereas that against EBITDA is 8.572.
Stock Price History:
The Beta on a monthly basis for ENOV is 1.46, which has changed by -0.35911363 over the last 52 weeks, in comparison to a change of 0.13054323 over the same period for the S&P500. Over the past 52 weeks, ENOV has reached a high of $49.83, while it has fallen to a 52-week low of $25.47. The 50-Day Moving Average of the stock is -2.00%, while the 200-Day Moving Average is calculated to be -22.11%.
Shares Statistics:
Over the past 3-months, ENOV traded about 1.47M shares per day on average, while over the past 10 days, ENOV traded about 1105790 shares per day. A total of 57.16M shares are outstanding, with a floating share count of 55.92M. Insiders hold about 2.16% of the company’s shares, while institutions hold 119.07% stake in the company. Shares short for ENOV as of 1753920000 were 6878051 with a Short Ratio of 4.67, compared to 1751241600 on 7925819. Therefore, it implies a Short% of Shares Outstanding of 6878051 and a Short% of Float of 18.090001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Current recommendations for the stock of the company come from 11.0 analysts. The consensus estimate for the next quarter is $0.86, with high estimates of $0.88 and low estimates of $0.8.
Analysts are recommending an EPS of between $3.18 and $3.08 for the fiscal current year, implying an average EPS of $3.13. EPS for the following year is $3.48, with 11.0 analysts recommending between $3.77 and $3.28.
Revenue Estimates
11 analysts predict $538.51M in revenue for the current quarter. It ranges from a high estimate of $546.8M to a low estimate of $533.44M. As of the current estimate, Enovis Corp’s year-ago sales were $505.22MFor the next quarter, 11 analysts are estimating revenue of $593.31M. There is a high estimate of $598.9M for the next quarter, whereas the lowest estimate is $585M.
A total of 11 analysts have provided revenue estimates for ENOV’s current fiscal year. The highest revenue estimate was $2.27B, while the lowest revenue estimate was $2.25B, resulting in an average revenue estimate of $2.26B. In the same quarter a year ago, actual revenue was $2.11BBased on 11 analysts’ estimates, the company’s revenue will be $2.4B in the next fiscal year. The high estimate is $2.43B and the low estimate is $2.38B.
